Coalition Efforts

Consumer Action is working on these important issues along with other organizations. If you would like to know more about these issues, please see “More Information” at the end of each article.

 

Postings

Seniors deserve a simplified Medicare enrollment process
Consumer Action joined Better Medicare Alliance (BMA), the leading research and advocacy organization supporting Medicare Advantage, in unveiling a new white paper that contains a set of comprehensive recommendations to reimagine Medicare enrollment and empower beneficiaries to make better sense of their coverage options. The coalition’s five-pronged plan, entitled “Empowering Beneficiaries and Modernizing Medicare Enrollment,” offers bold recommendations for reform, including shifting all Medicare enrollment responsibilities from the Social Security Administration to the Department of Health and Human Services.

Patients deserve access to cheaper prescription drugs
The Food and Drug Administration sought input for improvements to its generic drug approval process, including for complex generic drugs. Advocates stressed the importance of implementing policies that increase competition among drug companies and reduce barriers to cheaper prescription drugs. It’s time Americans have greater access to more affordable drugs and newly approved generic medicines.

The next COVID-19 relief package should include these critical consumer protections
Millions of people and small businesses in the United States are experiencing tremendous financial distress because of the COVID-19 pandemic. Unemployment is skyrocketing and families are struggling to put food on the table. Congress and the administration need to enact broad-based, efficient, and effective relief that goes far beyond the CARES Act to protect people’s homes, cars, bank accounts, income, and benefits so that they can weather this crisis. Consumer Action joined nearly 100 consumer, civil rights, community and other public interest groups weigh in on recommendations for Congress' next stimulus package.

Advocates call foul as CFPB hides consumer complaint narratives from public view
Consumer Action joined nearly three dozen consumer, civil rights, community, housing, and privacy groups in urging the Consumer Financial Protection Bureau (CFPB) to reconsider its decision to bury the narratives of consumer complaints, making it much harder for non-experts to find this essential material in its consumer complaint database. Access to the complaint narratives helps to educate and empower consumers to make wise financial decisions and meets the Bureau’s mandate to inform and protect consumers. Public access to this critical information also helps to hold companies accountable for their behavior in the financial marketplace.

Millions of struggling families need housing counseling now
In the economic fallout of the current pandemic, more than 20 million Americans are out of work. Black and Latino workers are experiencing disproportionate economic challenges, including an unemployment rate of 16.8 percent and 17.6 percent, respectively. American households are expected to face a wave of evictions and foreclosures even worse than they experienced in the last financial crisis. Coalition advocates wrote to Congress in support of the Coronavirus Housing Counseling Improvement Act, which expands access to housing counseling so that these individuals and families can get help in finding affordable ways to stay in their homes.

Labor Department should withdraw policy that lets private equity loot retirement plans
Nineteen organizations and individuals that advocate on behalf of consumers, workers, investors and retirees have called on the Department of Labor (DOL) to withdraw its controversial policy statement opening the door to private equity investments in 401(k) plans. These investments are likely to saddle middle-class retirement savers with high costs and lock them into unnecessarily complex investments that underperform publicly available alternatives. The coalition called on DOL to withdraw the policy statement until it can conduct a more careful and balanced analysis of the potential risks and benefits of including a private equity component in retirement plan investments.

AbbVie—Allergan merger a bad deal for consumers
As the Federal Trade Commission signs off on the $63 billion deal between AbbVie and Allergen, advocates warn that the merger will reduce competition in a number of markets where AbbVie and Allergan directly overlap with each other. The deal will also exacerbate competitive problems that already exist in the pharmaceutical drug industry relating to rebate walls and patent abuses.

All insurers must make coronavirus tests and treatment free to patients
Americans have been urged to seek medical help if they are showing symptoms of COVID-19, but out-of-pocket costs could put insured patients into serious medical debt, or worse, deter them from seeking treatment at all — causing undue suffering and death, and exacerbating the pandemic. A coalition of more than 80 advocacy groups came together to urge all health insurance corporations to waive all patient fees for care associated with COVID-19, including copays and deductibles.

Affordability should be paramount when the COVID-19 vaccine is released to the public
Consumer Action joined nearly 70 organizations in writing to President Trump, asking him to ensure that vaccines or treatments for the coronavirus disease (COVID-19), developed and purchased with U.S. taxpayer dollars, are reasonably priced and available to everyone. Americans will not accept President Trump allowing Big Pharma corporations to profit off a pandemic that continues to claim thousands of lives.

Congress: Pass a clean budget for FY2021
Advocates called on Congress to pass an upcoming federal budget that funds the things that Americans care about, not undo essential consumer and environmental safeguards through policy riders. Policy riders are attached to legislation and rarely have anything to do with the bill. In fact, most riders are handouts to big corporations and special favors for interest groups that could not become law on their own merits. As Congress prepares the federal budget for fiscal year 2021, no appropriations titles, package of bills, or continuing resolutions should pass if they contain poison pill policy riders that go against the public interest, including policies that ensure safe and healthy food, restrain Wall Street abuses, provide access to justice and fair housing, and guarantee access to safe healthcare.

Quick Menu

Support Consumer Action

Support Consumer

Join Our Email List

Optional Member Code
Facebook FTwitter T

Insurance Menu

Help Desk

Advocacy